Losing weight on GLP-1s reduces the physical load on weight-bearing joints, easing pain
Orentreich, N., Matias, J
Additionally, research suggests that semaglutide may also reduce A1C levels in people with or without diabetes, making it a dual-purpose treatment [5]
A systematic review and meta-analysis examining tirzepatide across seven randomized clinical trials and one observational study found something remarkable
This pharmacokinetic profile makes weekly dosing practical for patients, but individual metabolism rates vary significantly based on liver function, renal clearance, and body compositionfactors that clinical biomarkers can help quantify
edema, arthralgia, carpal tunnel syndrome) which are either transient or resolve with discontinuation of treatment